Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity
A contribution of epigenetic modifications to B cell tolerance has been proposed but not directly tested. Here we report that deficiency of ten-eleven translocation (Tet) DNA demethylase family members Tet2 and Tet3 in B cells led to hyperactivation of B and T cells, autoantibody production and lupus-like disease in mice. Mechanistically, in the absence of Tet2 and Tet3, downregulation of CD86, which normally occurs following chronic exposure of self-reactive B cells to self-antigen, did not take place. The importance of dysregulated CD86 expression in Tet2- and Tet3-deficient B cells was further demonstrated by the restriction, albeit not complete, on aberrant T and B cell activation following anti-CD86 blockade. Tet2- and Tet3-deficient B cells had decreased accumulation of histone deacetylase 1 (HDAC1) and HDAC2 at the Cd86 locus. Thus, our findings suggest that Tet2- and Tet3-mediated chromatin modification participates in repression of CD86 on chronically stimulated self-reactive B cells, which contributes, at least in part, to preventing autoimmunity.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Nature immunology - 21(2020), 8 vom: 22. Aug., Seite 950-961 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tanaka, Shinya [VerfasserIn] |
---|
Links: |
---|
Themen: |
B7-2 Antigen |
---|
Anmerkungen: |
Date Completed 04.11.2020 Date Revised 18.10.2021 published: Print-Electronic ErratumIn: Nat Immunol. 2020 Sep 21;:. - PMID 32958930 Citation Status MEDLINE |
---|
doi: |
10.1038/s41590-020-0700-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311507891 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311507891 | ||
003 | DE-627 | ||
005 | 20231225142413.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41590-020-0700-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1038.xml |
035 | |a (DE-627)NLM311507891 | ||
035 | |a (NLM)32572241 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tanaka, Shinya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.11.2020 | ||
500 | |a Date Revised 18.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumIn: Nat Immunol. 2020 Sep 21;:. - PMID 32958930 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A contribution of epigenetic modifications to B cell tolerance has been proposed but not directly tested. Here we report that deficiency of ten-eleven translocation (Tet) DNA demethylase family members Tet2 and Tet3 in B cells led to hyperactivation of B and T cells, autoantibody production and lupus-like disease in mice. Mechanistically, in the absence of Tet2 and Tet3, downregulation of CD86, which normally occurs following chronic exposure of self-reactive B cells to self-antigen, did not take place. The importance of dysregulated CD86 expression in Tet2- and Tet3-deficient B cells was further demonstrated by the restriction, albeit not complete, on aberrant T and B cell activation following anti-CD86 blockade. Tet2- and Tet3-deficient B cells had decreased accumulation of histone deacetylase 1 (HDAC1) and HDAC2 at the Cd86 locus. Thus, our findings suggest that Tet2- and Tet3-mediated chromatin modification participates in repression of CD86 on chronically stimulated self-reactive B cells, which contributes, at least in part, to preventing autoimmunity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a B7-2 Antigen |2 NLM | |
650 | 7 | |a Cd86 protein, mouse |2 NLM | |
650 | 7 | |a DNA-Binding Proteins |2 NLM | |
650 | 7 | |a Proto-Oncogene Proteins |2 NLM | |
650 | 7 | |a Dioxygenases |2 NLM | |
650 | 7 | |a EC 1.13.11.- |2 NLM | |
650 | 7 | |a Tet2 protein, mouse |2 NLM | |
650 | 7 | |a EC 1.13.11.- |2 NLM | |
650 | 7 | |a Tet3 protein, mouse |2 NLM | |
650 | 7 | |a EC 1.13.11.- |2 NLM | |
700 | 1 | |a Ise, Wataru |e verfasserin |4 aut | |
700 | 1 | |a Inoue, Takeshi |e verfasserin |4 aut | |
700 | 1 | |a Ito, Ayako |e verfasserin |4 aut | |
700 | 1 | |a Ono, Chisato |e verfasserin |4 aut | |
700 | 1 | |a Shima, Yoshihito |e verfasserin |4 aut | |
700 | 1 | |a Sakakibara, Shuhei |e verfasserin |4 aut | |
700 | 1 | |a Nakayama, Manabu |e verfasserin |4 aut | |
700 | 1 | |a Fujii, Kentaro |e verfasserin |4 aut | |
700 | 1 | |a Miura, Ikuo |e verfasserin |4 aut | |
700 | 1 | |a Sharif, Jafar |e verfasserin |4 aut | |
700 | 1 | |a Koseki, Haruhiko |e verfasserin |4 aut | |
700 | 1 | |a Koni, Pandelakis A |e verfasserin |4 aut | |
700 | 1 | |a Raman, Indu |e verfasserin |4 aut | |
700 | 1 | |a Li, Quan-Zhen |e verfasserin |4 aut | |
700 | 1 | |a Kubo, Masato |e verfasserin |4 aut | |
700 | 1 | |a Fujiki, Katsunori |e verfasserin |4 aut | |
700 | 1 | |a Nakato, Ryuichiro |e verfasserin |4 aut | |
700 | 1 | |a Shirahige, Katsuhiko |e verfasserin |4 aut | |
700 | 1 | |a Araki, Hiromitsu |e verfasserin |4 aut | |
700 | 1 | |a Miura, Fumihito |e verfasserin |4 aut | |
700 | 1 | |a Ito, Takashi |e verfasserin |4 aut | |
700 | 1 | |a Kawakami, Eiryo |e verfasserin |4 aut | |
700 | 1 | |a Baba, Yoshihiro |e verfasserin |4 aut | |
700 | 1 | |a Kurosaki, Tomohiro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature immunology |d 2000 |g 21(2020), 8 vom: 22. Aug., Seite 950-961 |w (DE-627)NLM10805523X |x 1529-2916 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2020 |g number:8 |g day:22 |g month:08 |g pages:950-961 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41590-020-0700-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2020 |e 8 |b 22 |c 08 |h 950-961 |